Provided by Tiger Fintech (Singapore) Pte. Ltd.

Outlook Therapeutics, Inc.

1.49
+0.0000
Volume:155.21K
Turnover:232.04K
Market Cap:47.71M
PE:-0.37
High:1.52
Open:1.49
Low:1.46
Close:1.49
Loading ...

Analysts Offer Insights on Healthcare Companies: IN8bio (INAB), Vigil Neuroscience Inc (VIGL) and Outlook Therapeutics (OTLK)

TIPRANKS
·
28 Nov 2024

Dow Falls Over 100 Points; US Crude Oil Stocks Decline

Benzinga
·
28 Nov 2024

Outlook Therapeutics Inc : Btig Cuts Target Price to $9 From $50

THOMSON REUTERS
·
27 Nov 2024

Outlook Therapeutics Shares Hit Record Low of $0.93 After Preliminary Results Show Eye Disorder Drug Failed to Meet Main Goal of Study

THOMSON REUTERS
·
27 Nov 2024

Why Is Eye Disease-Focused Outlook Therapeutics Stock Trading Lower On Wednesday?

Benzinga
·
27 Nov 2024

Outlook Therapeutics Trial of Eye Disease Treatment Misses Key Endpoint

Dow Jones
·
27 Nov 2024

Outlook Therapeutics Says Eye Disease Drug Fails Key Trial Endpoint; Shares Plunge

MT Newswires Live
·
27 Nov 2024

BUZZ-Outlook Therapeutics slumps as eye disease drug fails to meet key goal in study

Reuters
·
27 Nov 2024

BRIEF-Outlook Therapeutics Announces Preliminary Topline Results Of Norse Eight Clinical Trial

Reuters
·
27 Nov 2024

Outlook Therapeutics Shares Fall 53% Premarket After Preliminary Results Show Eye Disorder Drug Failed to Meet Main Goal of Study

THOMSON REUTERS
·
27 Nov 2024

Outlook Therapeutics reports preliminary results from Norse Eight trials

TIPRANKS
·
27 Nov 2024

Outlook Therapeutics Inc - Final Efficacy Data Expected in January 2025

THOMSON REUTERS
·
27 Nov 2024

Outlook Therapeutics Inc -Anticipate Resubmission of Bla in Calendar Q1 2025

THOMSON REUTERS
·
27 Nov 2024

Outlook Therapeutics® Announces Preliminary Topline Results of Norse Eight Clinical Trial

THOMSON REUTERS
·
27 Nov 2024

Outlook Therapeutics Inc - Ons-5010 Did Not Meet Non-Inferiority Endpoint in Norse Eight Trial

THOMSON REUTERS
·
27 Nov 2024

Owning 30% shares,institutional owners seem interested in Outlook Therapeutics, Inc. (NASDAQ:OTLK),

Simply Wall St.
·
26 Nov 2024